As per the research report, the size of the North America Adhesion Barrier Market was valued at USD 392.37 million in 2021 and estimated to be growing at a CAGR of 8.15%, to reach USD 580.53 million by 2026.
According to the National Cancer Institute, in 2019, approximately 1.75 million new cases of cancer were diagnosed in the United States. The increase in the geriatric population also significantly increases the use of adhesion barriers, as they suffer from various chronic diseases, increased incidence of gynecological disorders, neurological disorders, etc. heart disorders and ophthalmic disorders requiring surgery.
According to the World Health Organization (WHO), one in four people living in North America and Europe could be 65 or older by 2045. The number of people over age group 80 is expected to reach 428 million by 2050. In addition, with increasing urbanization and increasing inclination towards a healthy lifestyle, more people are expected to engage in various sporting activities. Hence, the result is an increase in sports-related injuries, which increases the use of anti-adhesion barriers. These factors play a key driving role in growth rate.
On the other hand, due to the growing threat of adherence, after surgical treatment, the market still today sees barriers in terms of usability, a lack of awareness on the importance of the treatment as well as the need for health requirements, restraint market growth.
The Covid-19 epidemic has posed a number of challenges for the health sector, weighing it down with a rapid number of cases. This has resulted in a reduction in the number of surgeries and, in turn, a weakening of the demand for adhesion barriers.
However, by mid-2021 the number of surgeries increased, leading to the sale of a variety of new opportunities for surgical tools and devices, such as adhesion barriers. This will cause better growth prospects for the adhesion barrier market in the region than in pre-pandemic business scenario.
Strict regulatory approvals and brand loyalty makes it difficult for new products to garner market sales, which can challenge the growth rate of the market.
This research report on the North America Adhesion Barrier Market has been segmented and sub-segmented into the following categories:
By Product Form:
By Surgical Application:
The Americas are currently at the forefront of the global market and are expected to maintain their leadership position throughout the analysis period, given the strong presence of a massive group of medical device suppliers. The growing number of comprehensive research and development activities and the increase in laparoscopic procedures will also drive the demand for adhesion barriers in the years to come
The increasing rate of surgeries in the region is well noted. Growth in the United States is driven by advancements in technology, older patients who expect higher levels of function, and reimbursement models that encourage complex fusion surgery.
Adhesion barriers are also useful in cancer surgeries. According to the American Cancer Society estimate, new cases of lung cancer in the United States for 2019 are expected to be around 2.35 million, and around 154,150 deaths are expected from lung cancer. The National Institutes of Health estimated that cancer treatment cost the United States a total of $ 150.5 billion in 2018, of which $ 14.4 billion was due to lung cancer. Surgeons believe they can cost-effectively reduce the risk of postoperative complications in patients through the use of adhesion barriers. Hence, these new advancements are expected to drive the market growth in North America.
Companies playing a dominant role in the North America Adhesion Barrier Market profiled in this report are Baxter International Inc., Medtronic Plc., C. R. Bard, Inc., Johnson & Johnson, Sanofi Group, Atrium Medical Corporation, Integra Lifesciences Corporation, Anika Therapeutics Inc., FzioMed, Inc., and MAST Biosurgery AG.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Synthetic Adhesion Barriers
184.108.40.206 Regenerated Cellulose
220.127.116.11 Hyaluronic Acid
18.104.22.168 Polythene Glycol
5.1.3 Natural Adhesion Barriers
22.214.171.124 Collagen & Protein
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Product Form
5.2.2 Film Adhesion Barriers
5.2.3 Gel Adhesion Barriers
5.2.4 Liquid Adhesion Barriers
5.2.5 Y-o-Y Growth Analysis, By Product Form
5.2.6 Market Attractiveness Analysis, By Product Form
5.2.7 Market Share Analysis, By Product Form
5.3 Surgical Applications
5.3.2 Gynaecological Surgeries
5.3.3 Cardiovascular Surgeries
5.3.4 Neurological Surgeries
5.3.5 Orthopaedic Surgeries
5.3.6 General/Abdominal Surgeries
5.3.7 Urological Surgeries
5.3.8 Reconstructive Surgeries
5.3.9 Other Surgeries
5.3.10 Y-o-Y Growth Analysis, By Surgical Applications
5.3.11 Market Attractiveness Analysis, By Surgical Applications
5.3.12 Market Share Analysis, By Surgical Applications
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Product Form
220.127.116.11 By Surgical Applications
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Product Form
188.8.131.52 By Surgical Applications
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Product Form
22.214.171.124 By Surgical Applications
6.2 United States
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Baxter International Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic Plc.
8.3 C. R. Bard, Inc.
8.4 Johnson & Johnson
8.5 Sanofi Group
8.6 Atrium Medical Corporation
8.7 Integra Lifesciences Corporation
8.8 Anika Therapeutics Inc.
8.9 FzioMed, Inc.
8.10 MAST Biosurgery AG
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures